Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Carlos Alberto Pereira TAVARES"'
Autor:
Eduardo Antonio Ferraz Coelho, Miguel Angel Chávez-Fumagalli, Lourena Emanuele Costa, Carlos Alberto Pereira Tavares, Manuel Soto, Luiz Ricardo Goulart
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 48, Iss 4, Pp 370-379 (2015)
AbstractPhage display is a high-throughput subtractive proteomic technology used for the generation and screening of large peptide and antibody libraries. It is based on the selection of phage-fused surface-exposed peptides that recognize specific li
Externí odkaz:
https://doaj.org/article/929003e63c464a7ba791bb309b248cb0
Autor:
Miguel Angel Chávez-Fumagalli, Tatiana Gomes Ribeiro, Rachel Oliveira Castilho, Simone Odília Antunes Fernandes, Valbert Nascimento Cardoso, Cecília Steinberg Perilo Coelho, Débora Vasconcelos Costa Mendonça, Manuel Soto, Carlos Alberto Pereira Tavares, André Augusto Gomes Faraco, Eduardo Antonio Ferraz Coelho
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 48, Iss 3, Pp 235-242 (2015)
Leishmaniasis is one of the six major tropical diseases targeted by the World Health Organization. It is a life-threatening disease of medical, social and economic importance in endemic areas. No vaccine is yet available for human use, and chemothera
Externí odkaz:
https://doaj.org/article/f8d70aeae8864101872ee0d579e634db
Autor:
Wilson Mayrink, Carlos Alberto Pereira Tavares, Rosangela Barbosa de Deus, Melina Barros Pinheiro, Tânia Mara Pinto Dabés Guimarães, Hélida Monteiro de Andrade, Carlos Alberto da Costa, Vicente de Paulo Coelho Peixoto de Toledo
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 105, Iss 1, Pp 86-91 (2010)
For decades thimerosal has been used as a preservative in the candidate vaccine for cutaneous leishmaniasis, which was developed by Mayrink et al. The use of thimerosal in humans has been banned due to its mercury content. This study addresses the st
Externí odkaz:
https://doaj.org/article/237c6aa878d849f4a259dcee2dcf380f
Autor:
Vivian Tamietti Martins, Miguel Angel Chávez-Fumagalli, Daniela Pagliara Lage, Mariana Costa Duarte, Esther Garde, Lourena Emanuele Costa, Viviane Grazielle da Silva, Jamil Silvano Oliveira, Danielle Ferreira de Magalhães-Soares, Santuza Maria Ribeiro Teixeira, Ana Paula Fernandes, Manuel Soto, Carlos Alberto Pereira Tavares, Eduardo Antonio Ferraz Coelho
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137683 (2015)
In the present study, two Leishmania infantum hypothetical proteins present in the amastigote stage, LiHyp1 and LiHyp6, were combined with a promastigote protein, IgE-dependent histamine-releasing factor (HRF); to compose a polyproteins vaccine to be
Externí odkaz:
https://doaj.org/article/3e9d38fe964a40038daef1019f0f00c3
Autor:
Vivian Tamietti Martins, Miguel Angel Chávez-Fumagalli, Daniela Pagliara Lage, Mariana Costa Duarte, Esther Garde, Lourena Emanuele Costa, Viviane Grazielle da Silva, Jamil Silvano Oliveira, Danielle Ferreira de Magalhães-Soares, Santuza Maria Ribeiro Teixeira, Ana Paula Fernandes, Manuel Soto, Carlos Alberto Pereira Tavares, Eduardo Antonio Ferraz Coelho
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141496 (2015)
Externí odkaz:
https://doaj.org/article/72dfd8c70ba64f8db7d8e6cf26bf8e02
Autor:
Lourena Emanuele Costa, Luiz Ricardo Goulart, Nathália Cristina de Jesus Pereira, Mayara Ingrid Sousa Lima, Mariana Costa Duarte, Vivian Tamietti Martins, Paula Sousa Lage, Daniel Menezes-Souza, Tatiana Gomes Ribeiro, Maria Norma Melo, Ana Paula Fernandes, Manuel Soto, Carlos Alberto Pereira Tavares, Miguel Angel Chávez-Fumagalli, Eduardo Antonio Ferraz Coelho
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110014 (2014)
BACKGROUND: The development of cost-effective prophylactic strategies to prevent leishmaniasis has become a high-priority. The present study has used the phage display technology to identify new immunogens, which were evaluated as vaccines in the mur
Externí odkaz:
https://doaj.org/article/06571cc1799245df98f8cdcd35f00066
Autor:
Fabio Ribeiro, Rômulo Teixeira de Mello, Carlos Alberto Pereira Tavares, John Robert Kusel, Paulo Marcos Zech Coelho
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 46, Iss 4, Pp 231-233 (2004)
The interaction between specific immune response to Schistosoma mansoni and praziquantel (PZQ) was studied in mice. In mice harboring concomitant immunity, 6-day-old parasites treated with PZQ were more effectively removed than 24h treated parasites
Externí odkaz:
https://doaj.org/article/363e1f053d984e2f9547fd777baccf9c
Autor:
Fernando Schemelzer de Moraes Bezerra, Paulo Marcos Zech Coelho, Carlos Alberto Pereira Tavares
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 35, Iss 4, Pp 337-344 (1993)
Aiming at demonstrating a decrease of acquired immunity after chemotherapeutic cure, a group of mice was infected with 25 Schistosoma mansoni cercariae (LE strain). A part of these animals was treated with 400 mg/kg oxamniquine, at 120 days after inf
Externí odkaz:
https://doaj.org/article/a74dcaeb78eb44d4be6d8e5e7183fef9
Autor:
Ana Paula FERNANDES, Elizabeth Cortez HERRERA, Wilson MAYRINK, Ricardo T. GAZZINELLI, Wen Yu LIU, Carlos Alberto da COSTA, Carlos Alberto Pereira TAVARES, Maria Norma MELO, Marilene Susan Marques MICHALICK, Reiner GENTZ, Evaldo NASCIMENTO
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 39, Iss 2, p 71 (1997)
In the search for Leishmania recombinant antigens that can be used as a vaccine against American Cutaneous Leishmaniasis, we identified a Leishmania (Leishmania) amazonensis recombinant protein of 33 kD (Larp33) which is recognized by antibodies and
Externí odkaz:
https://doaj.org/article/eaae4e16841c45cf886e8aff236ce911
Autor:
Mariana Costa Duarte, Daniela Pagliara Lage, Vívian Tamietti Martins, Miguel Angel Chávez-Fumagalli, Bruno Mendes Roatt, Daniel Menezes-Souza, Luiz Ricardo Goulart, Manuel Soto, Carlos Alberto Pereira Tavares, Eduardo Antonio Ferraz Coelho
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 49, Iss 4, Pp 398-407
Abstract: Visceral leishmaniasis (VL) is one of the most important tropical diseases worldwide. Although chemotherapy has been widely used to treat this disease, problems related to the development of parasite resistance and side effects associated w
Externí odkaz:
https://doaj.org/article/94ef84e8c4eb4d409ee254ac9a4b56ee